InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Explore the full record of transactions filed by Chin Richard, Chairman & CEO. Director active across 1 companies, notably Kindred Biosciences, Inc.. Cumulatively, 8 filings have been recorded. Total volume traded: €1.2m. The latest transaction was filed on 27 August 2021 — Disposition. Regulator: SEC (Form 4). The full history is free.
Declarations8 total
€13m1,709,271 shares@ €7.868195.6% of flow
Common Stock
SEC:0001250853-21-000092·
€13m1,709,271 shares@ €7.868147.8% of flow
Common Stock
SEC:0001250853-21-000092:0·
0320,000 shares0
Common Stock
SEC:0001250853-21-000081·
0320,000 shares0
Common Stock
SEC:0001250853-21-000081:0·
€309,87140,000 shares@ €7.74682.2% of flow
Common Stock
SEC:0001250853-21-000071·
€309,87140,000 shares@ €7.74681.1% of flow
Common Stock
SEC:0001250853-21-000071:0·
€306,16940,000 shares@ €7.65422.2% of flow
Common Stock
SEC:0001250853-21-000066·
€306,16940,000 shares@ €7.65421.1% of flow
Common Stock
SEC:0001250853-21-000066:0·
8 of 8 declarations
About Chin Richard
Richard Chin is the Chief Executive Officer of Kindred Biosciences, Inc., a biotechnology company dedicated to improving animal health. In this role, he oversees the operations and strategy of the company. His expertise in biotechnology is essential for the success of Kindred Biosciences, Inc.
